Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Pfizer: COVID vaccine supply ‘on track’, despite manufacturing delay

Deliveries of the Pfizer/BioNTech COVID vaccines are “on track” despite a “short-term reduction in supply”, the manufacturer has assured.

Pfizer announced last week that deliveries of its COVID-19 vaccines to several nations – including the UK – would be delayed, as its manufacturing site in the Belgian town of Puurs undergoes an expansion to increase its global output for 2021, from 1.3 billion doses to 2bn.

However, the manufacturer told C+D on Monday (January 18) that supplies for “nominated distribution centres are on track and progressing according to our agreed schedule” and projected volumes for the UK remains the same for the first quarter of the year.

The UK has secured 40 million doses of the Pfizer/BioNTech vaccine for 2021, according to the government.

The news comes as the first pharmacies in England start to offer the COVID-19 vaccination service and as ministers and healthcare leaders suggest that the programme will be rolled out to more pharmacies “as supplies allow”.

Commenting on the manufacturing delays in Puurs, a spokesperson for Pfizer told C+D: “We understand a change to deliveries has the potential to create uncertainty.

“We continue to liaise with the UK government and the vaccines taskforce to work through the short-term impact of these changes to our January deliveries and support the goals of the UK COVID-19 vaccination programme.”

Would you like to be involved in the UK's COVID-19 vaccination service?

Related Content


Stamford, Lincolnshire
£50-55,000 per annum

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts